GreenMark Secures Funding for Identification of Early Caries

GreenMark Biomedical Inc has announced it has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant to further develop its patented nanoparticle-based dental technology for detecting early-stage dental caries.

By The Editors On Nov 7, 2019 0

EAST LANSING, Mich. — GreenMark Biomedical Inc has announced it has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant to further develop its patented nanoparticle-based dental technology for detecting early-stage dental caries. The project involves collaboration with dental and biomaterials experts at the University of Michigan, Creighton University, Tufts University, and University of Colorado, and is being funded by the National Institute of Dental and Craniofacial Research of the National Institutes of Health.

GreenMark’s diagnostic product identifies early caries lesions can then be treated noninvasively, reducing the need for costly dental procedures. GreenMark’s core technology utilizes bioresorbable, starch-based nanoparticles which degrade into harmless materials by the time the patient is ready to leave the dental office.